Open Access

Overexpression of the anti-apoptotic protein BAG3 in human choroidal melanoma: A case report

  • Authors:
    • Tatsuya Yunoki
    • Yoshiaki Tabuchi
    • Takashi Kondo
    • Yoko Ishii
    • Atsushi Hayashi
  • View Affiliations

  • Published online on: March 30, 2017     https://doi.org/10.3892/ol.2017.5958
  • Pages: 4169-4172
  • Copyright: © Yunoki et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Bcl-2-associated athanogene 3 (BAG3), a co-chaperone of heat shock protein 70 (HSP70), exerts anti-apoptotic effects in various malignant tumors. However, relationships between choroidal melanoma and BAG3 are poorly studied. This study investigated the expression of BAG3 in a case of human choroidal melanoma. Funduscopy, computed tomography, and single-photon emission computed tomography with the intravenous injection of N‑isopropyl‑p‑[123I] iodoamphetamine strongly indicated choroidal melanoma in a 68‑year‑old woman. Accordingly, we carried out an enucleation and pathological diagnosis. Proteins and total RNA were extracted from normal retinochoroidal and tumor tissues. Proteins were also extracted from ocular nevus tissues of other patients. We examined the expression of BAG3 protein and mRNA using Western blotting and the real‑time quantitative polymerase chain reaction, respectively. Immunohistochemical stains were positive for melan-A, HMB‑45, and S‑100. Histopathology confirmed a choroidal melanoma. The expression of BAG3 protein and mRNA in the choroidal melanoma tissue was upregulated with respect to both normal retinochoroidal tissue and ocular nevus tissues from other patients. Because BAG3 may inhibit apoptosis of choroidal melanoma and facilitate its survival, overexpression of this gene product may be a prognostic marker and therapeutic target.

Introduction

Choroidal melanoma is the most common intraocular tumor in adults, and it metastasizes mainly to the liver (1). Poor prognosis is related to various clinical factors such as tumor size (2). Furthermore, various molecular factors are associated with poor prognosis (3,4).

Heat shock proteins (HSPs) function as molecular chaperones and exert cytoprotective effects. Among the HSPs, proteins from the HSP70 family play central roles as molecular chaperones. Bcl-2-associated athanogene 3 (BAG3) belongs to a family of co-chaperones that interacts with the ATPase domain of HSP70 (5). Although BAG3 is expressed weakly in normal cells, it is overexpressed in various malignant tumors (614). In melanoma cells, BAG3 is upregulated, and exerts cell survival and anti-apoptotic effects (1517). However, relationships between choroidal melanoma and BAG3 are poorly studied. Therefore, we investigated the expression of BAG3 in human choroidal melanoma as compared to normal and ocular nevus tumor tissues.

Case report

Patients and clinical materials

A 68-year-old woman was referred to Toyama University Hospital for further evaluation of a left intraocular mass. Funduscopy revealed a pigmented choroidal mass in the temporal fundus of her left eye. B-Mode ultrasonography revealed a choroidal protrusion (Fig. 1A). Computed tomography revealed an enhanced intraocular mass (Fig. 1B). Single-photon emission computed tomography revealed a high accumulation of N-isopropyl-p-[123I] iodoamphetamine after its intravenous injection (Fig. 1C) (18).

To definitively treat this strongly suspected case of choroidal melanoma, we enucleated the eye. Immunohistochemical stains were positive for melan-A (Fig. 2), HMB-45, and S-100 (not shown) (19). Histopathology confirmed choroidal melanoma without vascular or optic nerve invasion. Additionally, we surgically resected a conjunctival tumor from a 44-year-old man (Fig. 3A) and a lid tumor from a 74-year-old man (Fig. 3B); these tumors were diagnosed as conjunctival nevus and lid nevus, respectively.

Normal retinochoroidal and melanoma tissue samples were obtained from the enucleated eye (Fig. 4), and nevus tissue samples were obtained from the resected tumor tissues (Fig. 3A and B). Our procedures conformed to the tenets of the World Medical Association's Declaration of Helsinki. Written informed consent was obtained from the patients after provision of sufficient information about the procedures.

Western blotting

Protein extracts were prepared by homogenizing tissue samples in a lysis buffer (150 mM NaCl, 1% Nonidet P-40, and 50 mM Tris-HCl, pH 8.0) containing a protease inhibitor cocktail (Nacalai Tesque, Kyoto, Japan). After electrophoresis on sodium dodecyl sulfate-polyacrylamide gels, proteins were transferred electrophoretically onto polyvinylidene fluoride membranes. The following primary antibodies were used: rabbit monoclonal anti-BAG3 (GTX62327; GeneTex Inc., Irvine, CA, USA); mouse monoclonal anti-HSP70 (SR-B810; MBL, Nagoya, Japan); rabbit monoclonal anti anti-HSF1 (GTX62022; GeneTex Inc.) and mouse monoclonal anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (MAB374; Millipore, Temecula, CA, USA). The immunoreactive proteins were visualized using a luminescence image analyzer (LAS 4000mini; GE Healthcare, Tokyo, Japan) with an enhanced chemiluminescence detection system. GAPDH served as the loading control.

RNA isolation

Using an RNeasy Total RNA Extraction kit (Qiagen K.K., Tokyo, Japan), total RNA was extracted from tissue samples and treated with on-column DNase I (RNase-free DNase kit, Qiagen K.K.) (20).

Quantitative polymerase chain reaction (qPCR)

qPCR was performed on a Real-Time PCR Mx3005P system (Agilent Technologies, Santa Clara, CA, USA) using a SYBR PreMix ExTaq kit (Takara Bio, Inc., Shiga, Japan). The relevant primer sequences are listed in Table I. mRNA expression levels for each protein were normalized to the mRNA expression level for GAPDH (20).

Table I.

Nucleotide sequences of primers for target genes.

Table I.

Nucleotide sequences of primers for target genes.

GenesNucleotide sequence (5′-3′)GenBank accession no.
Bcl-2-associated athanogene 3
  Sense CGACCAGGCTACATTCCCATNM_004281
  Antisense TCTGGCTGAGTGGTTTCTGG
Glyceraldehyde 3-phosphate dehydrogenase
  Sense AAGGCTGGGGCTCATTTGCANM_002046
  Antisense ATGACCTTGCCCACAGCCTT
Statistical analysis

Measurements are reported as means ± standard deviations. Student's t-test was used for statistical analysis, and P<0.05 was considered statistically significant.

Results

To analyze the involvement of BAG3 within a choroidal melanoma, we examined its protein and mRNA expression levels using western blotting and qPCR, respectively. The BAG3 protein level in the human choroidal melanoma tissue was upregulated compared to that in normal retinochoroidal tissue (Fig. 5A). Furthermore, as observed using Western blotting, the expression levels of heat shock factor 1 (HSF1) and HSP70 were upregulated in human choroidal melanoma relative to expression levels in normal retinochoroidal tissues (Fig. 5A). Similarly, qPCR indicated that the BAG3 mRNA level in the human choroidal melanoma tissue was significantly higher than that in normal retinochoroidal tissue (n=4, P=0.000291) (Fig. 5B). Additionally, we confirmed BAG3 expression in choroidal melanoma using immunohistochemical analysis (Fig. 5C).

Western blots also indicated that the BAG3 level in the human choroidal melanoma tissue was upregulated compared to those in nevus tissue samples from other patients. Moreover, BAG3 levels in the conjunctival nevus were higher than those in the lid nevus (Fig. 6). These findings suggest that BAG3 was upregulated in the human choroidal melanoma relative to normal retinochoroidal and nevus tissues.

Discussion

The mechanisms of choroidal melanoma progression and metastasis remain poorly understood, and treatment options are limited. Regardless of the progress of diagnostic technology, choroidal melanoma causes death due to liver metastasis (21). Accordingly, the study of choroidal melanoma-specific biomarkers is important for improving prognosis accuracy.

It is thought that an association between the heat shock response and melanoma is important. HSF1 is required for melanoma invasion and metastasis (22). BAG3, a co-chaperone of HSP70, is overexpressed in multiple malignant tumors and exerts anti-apoptotic effects (1517). Observations in vitro and in vivo indicate that the induction of BAG3 is at least partly mediated by the activation of HSF1 (23). In this study, BAG3 levels were upregulated via HSF1 activation in human choroidal melanoma relative to its expression levels in normal retinochoroidal tissues. However, little is known about the anti-apoptotic role of BAG3 in human choroidal melanoma. To our knowledge, we are the first to report overexpression of BAG3 protein and mRNA in human choroidal melanoma relative to expression levels in normal retinochoroidal and ocular nevus tissues. Franco et al reported that BAG3 levels in eye melanoma are relatively low, but are related to metastasis at other sites (15). It is possible that BAG3-positive choroidal melanoma is associated with a poor prognosis. We think that careful follow-up of patients is necessary in BAG3-positive choroidal melanoma.

Similar to its effects in other malignant tumors, BAG3 may contribute to survival through anti-apoptotic activity in choroidal melanoma. We believe that BAG3 may be a prognostic marker and therapeutic target. Further investigation is necessary to understand the relationships between choroidal melanoma and BAG3.

In conclusion, BAG3 is overexpressed in human choroidal melanoma relative to other related tissues. Our findings suggest that BAG3 may offer a therapeutic target for patients with choroidal melanoma.

Acknowledgements

This study was supported in part by a Grant-in-Aid for Scientific Research (16K20309) from the Japan Society for the Promotion of Science.

Glossary

Abbreviations

Abbreviations:

BAG3

Bcl-2-associated athanogene 3

GAPDH

glyceraldehyde 3-phosphate dehydrogenase

HSF1

heat shock factor 1

HSP70

heat shock protein 70

HSPs

heat shock proteins

qPCR

quantitative polymerase chain reaction

SD

standard deviation

References

1 

Wöll E, Bedikian A and Legha SS: Uveal melanoma: Natural history and treatment options for metastatic disease. Melanoma Res. 9:575–581. 1999. View Article : Google Scholar : PubMed/NCBI

2 

Shields CL, Furuta M, Thangappan A, Nagori S, Mashayekhi A, Lally DR, Kelly CC, Rudich DS, Nagori AV, Wakade OA, et al: Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 127:989–998. 1999. View Article : Google Scholar

3 

Mooy CM and De Jong PT: Prognostic parameters in uveal melanoma: A review. Surv Ophthalmol. 41:215–228. 1996. View Article : Google Scholar : PubMed/NCBI

4 

Scholes AG, Damato BE, Nunn J, Hiscott P, Grierson I and Field JK: Monosomy 3 in uveal melanoma: Correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci. 44:1008–1011. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Takayama S, Xie Z and Reed JC: An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem. 274:781–786. 1999. View Article : Google Scholar : PubMed/NCBI

6 

Liao Q, Ozawa F, Friess H, Zimmermann A, Takayama S, Reed JC, Kleeff J and Büchler MW: The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines. FEBS Lett. 503:151–157. 2001. View Article : Google Scholar : PubMed/NCBI

7 

Kassis JN, Virador VM, Guancial EA, Kimm D, Ho AS, Mishra M, Chuang EY, Cook J, Gius D and Kohn EC: Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasion. J Pathol. 218:495–504. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Chiappetta G, Ammirante M, Basile A, Rosati A, Festa M, Monaco M, Vuttariello E, Pasquinelli R, Arra C, Zerilli M, et al: The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Clin Endocrinol Metab. 92:1159–1163. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Wang HQ, Liu BQ, Gao YY, Meng X, Guan Y, Zhang HY and Du ZX: Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression. Br J Pharmacol. 158:1405–1412. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Suzuki M, Iwasaki M, Sugio A, Hishiya A, Tanaka R, Endo T, Takayama S and Saito T: BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells. Cancer Lett. 303:65–71. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Tang JT, Wang JL, Du W, Hong J, Zhao SL, Wang YC, Xiong H, Chen HM and Fang JY: MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Carcinogenesis. 32:1207–1215. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Festa M, Del Valle L, Khalili K, Franco R, Scognamiglio G, Graziano V, de Laurenzi V, Turco MC and Rosati A: BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol. 178:2504–2512. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Liu P, Xu B, Li J and Lu H: BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis. FEBS Lett. 583:401–406. 2009. View Article : Google Scholar : PubMed/NCBI

14 

Romano MF, Festa M, Pagliuca G, Lerose R, Bisogni R, Chiurazzi F, Storti G, Volpe S, Venuta S, Turco MC and Leone A: BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis. Cell Death Differ. 10:383–385. 2003. View Article : Google Scholar : PubMed/NCBI

15 

Franco R, Scognamiglio G, Salerno V, Sebastiani A, Cennamo G, Ascierto PA, Botti G, Turco MC and Rosati A: Expression of the anti-apoptotic protein BAG3 in human melanomas. J Invest Dermatol. 132:252–254. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Basile A, Zeppa R, Pasquino N, Arra C, Ammirante M, Festa M, Barbieri A, Giudice A, Pascale M, Turco MC and Rosati A: Exposure to 50 Hz electromagnetic field raises the levels of the anti-apoptotic protein BAG3 in melanoma cells. J Cell Physiol. 226:2901–2907. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Ammirante M, Rosati A, Arra C, Basile A, Falco A, Festa M, Pascale M, d'Avenia M, Marzullo L, Belisario MA, et al: IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci USA. 107:7497–7502. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Goto H: Clinical efficacy of 123I–IMP SPECT for the diagnosis of malignant uveal melanoma. Int J Clin Oncol. 9:74–78. 2004. View Article : Google Scholar : PubMed/NCBI

19 

Levasseur SD, Paton KE, van Raamsdonk CD, Heran MK and White VA: Mutation of GNAQ in a cytologically unusual choroidal melanoma in an 18-month-old child. JAMA Ophthalmol. 131:810–812. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Tabuchi Y, Yunoki T, Hoshi N, Suzuki N and Kondo T: Genes and gene networks involved in sodium fluoride-elicited cell death accompanying endoplasmic reticulum stress in oral epithelial cells. Int J Mol Sci. 15:8959–8978. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Spanknebel K, Coit DG, Bieligk SC, Gonen M, Rosai J and Klimstra DS: Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: Recommendations for standardizing pathologic analysis. Am J Surg Pathol. 29:305–317. 2005. View Article : Google Scholar : PubMed/NCBI

22 

Nakamura Y, Fujimoto M, Fukushima S, Nakamura A, Hayashida N, Takii R, Takaki E, Nakai A and Muto M: Heat shock factor 1 is required for migration and invasion of human melanoma in vitro and in vivo. Cancer Lett. 354:329–335. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Franceschelli S, Rosati A, Lerose R, de Nicola S, Turco MC and Pascale M: Bag3 gene expression is regulated by heat shock factor 1. J Cell Physiol. 215:575–577. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June-2017
Volume 13 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yunoki T, Tabuchi Y, Kondo T, Ishii Y and Hayashi A: Overexpression of the anti-apoptotic protein BAG3 in human choroidal melanoma: A case report. Oncol Lett 13: 4169-4172, 2017
APA
Yunoki, T., Tabuchi, Y., Kondo, T., Ishii, Y., & Hayashi, A. (2017). Overexpression of the anti-apoptotic protein BAG3 in human choroidal melanoma: A case report. Oncology Letters, 13, 4169-4172. https://doi.org/10.3892/ol.2017.5958
MLA
Yunoki, T., Tabuchi, Y., Kondo, T., Ishii, Y., Hayashi, A."Overexpression of the anti-apoptotic protein BAG3 in human choroidal melanoma: A case report". Oncology Letters 13.6 (2017): 4169-4172.
Chicago
Yunoki, T., Tabuchi, Y., Kondo, T., Ishii, Y., Hayashi, A."Overexpression of the anti-apoptotic protein BAG3 in human choroidal melanoma: A case report". Oncology Letters 13, no. 6 (2017): 4169-4172. https://doi.org/10.3892/ol.2017.5958